Article Information
History
- September 25, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Eme Ekeng1,*,
- Serges Tchatchouang2,*,
- Blaise Akenji3,
- Bassira Boubacar Issaka4,
- Ifeoluwa Akintayo5,
- Christopher Chukwu1,
- Ibrahim Dan Dano4,
- Sylvie Melingui3,
- Ousmane Sani4,
- Michael Oladotun Popoola1,
- Ariane Nzouankeu2,
- Yap Boum6,
- Francisco J Luquero6,
- Anthony Ahumibe1,
- Dhamari Naidoo7,
- Andrew S Azman8,
- Justin Lessler8 and
- Shirlee Wohl8,*
- 1Nigeria Centre for Disease Control, Abuja, Nigeria
- 2Centre Pasteur du Cameroun, Yaoundé, Cameroon
- 3National Public Health Laboratory, Yaoundé, Cameroon
- 4Centre de Recherche Médicale et Sanitaire, Niamey, Niger
- 5Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria
- 6Epicentre, Paris, France
- 7World Health Organization Nigeria, Abuja, Nigeria
- 8Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States
- ↵*Corresponding author; email: swohl{at}jhu.edu
↵* authors contributed equally
Posted September 25, 2020.
Persistence of the T12 Vibrio cholerae O1 lineage in West Africa: Insights from a Regional Sequencing Workshop
